Ecosystem Manager – Kisunla at Eli Lilly and Company

Seoul, South Korea, South Korea

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Bachelor’s or Master’s degree in Business, Life Sciences, or related field
7+ years in healthcare, market access, or pharmaceutical industry
Strong B2B experience; insurance company experience preferred
Proven negotiation and problem-solving skills; ability to deliver innovative funding solutions
Strong problem-solving skills; strategy consulting background highly desired
Business-proficient level of English; excellent communication and stakeholder management

Responsibilities

Identify and negotiate with private insurance companies to secure coverage for Kisunla treatment
Develop strategies to find alternative sources of private funding (e.g., patient assistance programs, partnerships) to reduce financial barriers
Collaborate with hospitals, diagnostic providers, and payers to integrate funding solutions into patient access plans
Support launch readiness by ensuring financial pathways align with diagnostic and treatment infrastructure
Provide insights to Market Access and Brand teams on funding gaps and opportunities

Skills

market access

stakeholder engagement

negotiation

B2B

insurance coverage

patient assistance programs

strategy consulting

problem-solving

communication

pharmaceutical industry

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free